Tsumura
Tsumura & Co is a major Japanese pharmaceutical enterprise headquartered in Tokyo, Japan. The company specializes in the research, production, and wholesale distribution of traditional Japanese herbal medicines (Kampo medicines), pharmaceuticals, and natural health products utilized in clinical practices and medical institutions to treat a range of conditions. Principal revenue is derived through wholesale manufacturing sales of Kampo pharmaceutical products. Tsumura & Co is publicly listed on the Tokyo Stock Exchange.
4 of the funds FundTelligence covers report a position in Tsumura.
- Legal name
- Tsumura & Co
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 4
Funds holding Tsumura
- Schroder ISF Japanese Equity — Schroders · 0.77 % (full portfolio disclosed, June 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)